Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Fbg, come on man. Ig obviously meant $250 million to be the upfront payment, not the overall value of a potential AXAL deal for US + EU. That would make zero sense. Seriously, you think ADXS' lead product that is in phase 3 with an SPA, and with Avastin's $6 billion annual revenues for comparison, would simply be given away for peanuts? For less than half of the preclinical NEO? All because the manipulators have taken the SP down to senseless levels? If you care about your investment, you have to reevaluate your expectations for the company, independent of the manipulation garbage being perpetrated on the stock.